Qamzova™ (meloxicam) – New drug approval
April 22, 2025 - The FDA approved Nanjing Delova Biotech’s Qamzova (meloxicam), for use in adults for the management of moderate-to-severe pain, alone or in combination with non-nonsteroidal anti-inflammatory drug (NSAID) analgesics.
Download PDF
